EssilorLuxottica (EL) EUR 0.35

Sell:€267.00Buy:€270.00€2.00 (0.75%)

Paris CAC 40:1.10%
Market closed | Prices delayed by at least 15 minutes
Sell:€267.00
Buy:€270.00
Change:€2.00 (0.75%)
Market closed | Prices delayed by at least 15 minutes
Sell:€267.00
Buy:€270.00
Change:€2.00 (0.75%)
Market closed | Prices delayed by at least 15 minutes

Company Information

About this company

EssilorLuxottica SA is a France-based ophthalmic company. The Company designs, distributes, manufactures, and markets a range of lenses, frames, and sunglasses to improve and protect eyesight. It also develops and markets equipment for prescription laboratories and instruments, and services for eye care professionals. It operates through three segments: Lenses and Optical Instruments, which includes corrective lenses, optical instruments intended for opticians and optometrists; Equipment, which includes machines and consumables used by plants and prescription laboratories, and Sunglasses & Readers, which encompasses non-prescription reading glasses and non-prescription sunglasses. EssilorLuxottica's assets include recognized brands, such as Ray-Ban and Oakley for eyewear, Varilux and Transitions for ophthalmic optical technologies, and Sunglass Hut and Lenscrafters for international distribution networks.

Key people

Francesco Milleri
Chairman of the Board, Chief Executive Officer
Paul du Saillant
Deputy Chief Executive Officer, Non-Independent Director
Stefano Grassi
Chief Financial Officer
Jean-Luc Biamonti
Lead Independent Director
Margot Bard
Director, Employee Representative
Romolo Bardin
Non-Independent Director
Sebastien Brown
Director, Employee Representative
Mario Notari
Non-Independent Director
Click to see more

Key facts

  • EPIC
    EL
  • Location
    France
  • Sector
    Healthcare
  • Industry
    Medical Equipment & Supplies
  • ISIN
    FR0000121667
  • Market cap
    €121.42bn
  • Employees
    196,754
  • Shares in issue
    457.51m
  • Exchange
    Euronext Paris
  • Index
    CAC 40 Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.